(Reuters) -Pfizer (PFE) said on Monday it would acquire drug developer Metsera (MTSR) in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the ...

Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...

Investing.com-- Pfizer Inc (NYSE:PFE) is close to launching a $7.3 billion takeover offer for anti-obesity drug maker Metsera Inc (NASDAQ:MTSR), which could be the former’s biggest deal in two years ...

CBS‘s telecast of the 77th Emmy Awards brought in 7.4 million viewers on Sunday night. That average marks an 8% increase from the 6.9 million viewers achieved by last year’s ceremony, which aired on ...

By Mariam Sunny and Michael Erman (Reuters) - Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a ...

(Reuters) - Cybersecurity firm Netskope is now aiming for a valuation of up to $7.26 billion in its U.S. initial public offering after raising the proposed price range, it said on Tuesday, ...

OSLO, Sept 17 (Reuters) - Switzerland-based security services firm Verisure said on Wednesday it plans to list on the Stockholm bourse, aiming to raise 3.1 billion euros ($3.7 billion) in what could ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 9月17日，一则来路不明的“小作文”在二级 ...

Nvidia owned six AI stocks at the end of Q2. Most of them remain unprofitable. One stock in Nvidia's portfolio stands out because of its valuation and growth prospects. Most of Nvidia's AI bets are ...

(The Center Square) - California is scrambling to avoid an automatic 3.7% payroll tax increase to cover its projected $23.2 billion debt to the federal government for COVID-era unemployment benefits ...

(Reuters) -Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the fast-growing obesity ...